Atlas Trials

Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Clinical trial NCT06134414 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06134414
Sponsor
Wuhan Createrna Science and Technology Co., Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Start date
2025-12-01
Primary completion
2027-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.